RAUMEDIC Sustainability Profile
RAUMEDIC AG, headquartered in Germany, is a leading player in the medical technology industry, specialising in the development and production of high-quality polymer solutions for medical applications. Founded in 1949, the company has established a strong presence in Europe and North America, focusing on critical areas such as catheter systems, tubing, and custom medical devices. With a commitment to innovation, RAUMEDIC stands out for its advanced manufacturing processes and expertise in biocompatible materials. The company’s core products are designed to meet stringent regulatory standards, ensuring safety and reliability in healthcare settings. RAUMEDIC has achieved notable milestones, including certifications that underscore its dedication to quality and excellence in the medical field. As a trusted partner for healthcare providers, RAUMEDIC continues to enhance patient care through its cutting-edge solutions.
DitchCarbon Score
How does RAUMEDIC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RAUMEDIC's score of 33 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
RAUMEDIC's reported carbon emissions
In 2023, RAUMEDIC reported total carbon emissions of approximately 68,034 kg CO2e globally, with specific emissions of about 2,499 kg CO2e from Scope 1 and about 6,835 kg CO2e from Scope 2. Notably, Scope 3 emissions accounted for about 58,700 kg CO2e, highlighting the significant impact of upstream activities. Comparatively, in 2022, the company’s global emissions were approximately 84,921,000 kg CO2e, with Scope 1 emissions at about 2,329,000 kg CO2e, Scope 2 at about 7,148,000 kg CO2e, and Scope 3 emissions reaching approximately 75,444,000 kg CO2e. This indicates a substantial reduction in total emissions from 2022 to 2023. RAUMEDIC's emissions data is cascaded from its parent company, REHAU Industries SE & Co. KG, reflecting a corporate family relationship. However, there are currently no specific reduction targets or climate pledges documented for RAUMEDIC, which suggests a need for further commitment to climate action within the industry context. Overall, while RAUMEDIC has made strides in emissions reporting, the absence of defined reduction initiatives indicates an opportunity for enhanced climate commitments moving forward.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 2,329,000 | 0,000,000 | 0,000 |
| Scope 2 | 7,148,000 | 0,000,000 | 0,000 |
| Scope 3 | 75,444,000 | 00,000,000 | - |
How Carbon Intensive is RAUMEDIC's Industry?
How Carbon Intensive is RAUMEDIC's Location?
RAUMEDIC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
RAUMEDIC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
